GENE TESTS FOR COLON CANCER RISK--PSYCHOSOCIAL STUDIES
结肠癌风险的基因测试——社会心理研究
基本信息
- 批准号:2209506
- 负责人:
- 金额:$ 28.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 1997-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The main goal of this proposal is to develop appropriate comprehensive
counseling guidelines for predictive colon cancer gene testing by: (1)
assessing perceptions and attitudes toward the gene tests, including their
social and psychological determinants, and (2) assessing the impact of the
test on at-risk persons. Our specific aims are:
1. To characterize in at-risk individuals those psychosocial factors that
predict willingness to undergo genetic testing for colon cancer, to
determine projected uses that will be made of the gene test, and to
determine the influence of social context, primarily family culture, in
shaping at-risk individuals' attitudes toward and perceptions of the gene
test. This will be accomplished by a mail survey of 1,000 adults at risk
for colon cancer.
2. To compare attitudes toward and perceptions of genetic testing for
colon cancer between white and African-American individuals (and a
subsample of their families). This will be accomplished with the mail
survey data and by qualitative telephone interviews with members of 50
families (25 white, 25 African-American) sampled from the mail survey.
3. To identify predictors of psychological distress associated with pre-
and post-disclosure cancer risk perception based on: experiences with
cancer, knowledge/beliefs/feelings about cancer, implicit models of
illness regarding cancer, cancer risk perceptions, coping behaviors, and
tolerance for ambiguity. We will offer MSH2 and MLH1 gene tests to 200
individuals at high risk for colon cancer, based on family history. Data
will be collected by questionnaire and interviews before and after gene
testing (at one month, six months, and one year post disclosure). The gene
test will result in one of three possible outcomes: definite gene-
positive, definite gene-negative, and inconclusive gene-negative. The
first two outcomes are expected when the mutation in the family is known;
the last outcome may occur when the mutation is not known, but the family
history is strongly suggestive of hereditary colon cancer. We will
stratify on the three outcomes and compare pre- and post disclosure
measures of distress and attitudes.
4. To assess post disclosure prevention-oriented health behaviors among
persons receiving gene positive, gene negative and inconclusive test
results. Because screening recommendations may vary with age, we will
stratify our analyses by age groups as well as gene test outcome.
该提案的主要目标是开发适当的综合
预测性结肠癌基因测试指南:(1)
评估对基因测试的看法和态度,包括
社会和心理决定因素,以及(2)评估
对高危人士进行测试。我们的具体目的是:
1。要在风险中表征那些心理社会因素
预测对结肠癌进行基因检测的意愿,
确定将由基因测试制成的投影用途,然后
确定社会背景的影响,主要是家庭文化,
塑造高危个人对基因的态度和看法
测试。这将通过对1000名处于危险的成年人的邮件调查来完成
结肠癌。
2。比较对基因检测的态度和看法
白人和非裔美国人之间的结肠癌(以及
家人的子样本)。这将通过邮件完成
调查数据以及通过定性电话访谈与50位成员
从邮件调查中取样的家庭(25名白人,25名非裔美国人)。
3。确定与前相关的心理困扰的预测因素
基于:
癌症,知识/信念/对癌症的感觉,隐性模型
关于癌症,癌症风险感知,应对行为和
对歧义的容忍度。我们将提供MSH2和MLH1基因测试200
基于家族史,患有结肠癌高风险的人。数据
将通过问卷调查和吉恩之后的访谈收集
测试(披露后一个月,六个月和一年)。基因
测试将导致三个可能的结果之一:确定的基因 -
阳性,确定的基因阴性和不确定的基因阴性。这
当家族突变已知时,预计会有前两个结果。
当突变不知道,但家庭可能会发生最后的结果
历史强烈暗示了遗传性结肠癌。我们将
对三个结果进行分层并比较披露前后
苦难和态度的衡量标准。
4.评估预防后披露的预防健康行为
接受基因阳性,基因阴性和尚无定论测试的人
结果。由于筛查建议可能随着年龄的增长而变化,我们将
按年龄组以及基因测试结果对我们的分析进行分层。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
GLORIA M. PETERSEN的其他基金
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
2 型糖尿病、胰腺炎和癌症中的外分泌和内分泌胰腺
- 批准号:1047157010471570
- 财政年份:2021
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
梅奥诊所生物标志物验证和胰腺癌早期检测的前瞻性资源
- 批准号:1042757510427575
- 财政年份:2016
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
梅奥诊所生物标志物验证和胰腺癌早期检测的前瞻性资源
- 批准号:97689739768973
- 财政年份:2016
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
梅奥诊所生物标志物验证和胰腺癌早期检测的前瞻性资源
- 批准号:93529009352900
- 财政年份:2016
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
梅奥诊所生物标志物验证和胰腺癌早期检测的前瞻性资源
- 批准号:93165749316574
- 财政年份:2016
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
2 型糖尿病、胰腺炎和癌症中的外分泌和内分泌胰腺
- 批准号:1068446410684464
- 财政年份:2015
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
2 型糖尿病、胰腺炎和癌症中的外分泌和内分泌胰腺
- 批准号:1025444610254446
- 财政年份:2015
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
2 型糖尿病、胰腺炎和癌症中的外分泌和内分泌胰腺
- 批准号:1026346110263461
- 财政年份:2015
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
相似国自然基金
华北平原粮食主产区小农户参与农业绿色生产的行为驱动及其激励机制研究
- 批准号:72303222
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
融合语言和认知图谱的心理内隐态度自动化分析与智能对话应用
- 批准号:62376188
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
复杂开放场景下的多模态度量学习方法研究
- 批准号:62302372
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
两种风险态度下广义第二价格拍卖理论的比较研究与实验检验
- 批准号:72361027
- 批准年份:2023
- 资助金额:26 万元
- 项目类别:地区科学基金项目
服务业一线员工应对机器人融入的行为策略研究:基于接近和规避框架
- 批准号:72372005
- 批准年份:2023
- 资助金额:40.00 万元
- 项目类别:面上项目
相似海外基金
Toward Racial Equity and Justice in Human Papillomavirus (HPV) Vaccination: An Exploratory Study with Cape Verdean Parents
人乳头瘤病毒(HPV)疫苗接种中的种族公平和正义:佛得角家长的探索性研究
- 批准号:1057408610574086
- 财政年份:2023
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:1045221710452217
- 财政年份:2022
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:1067083810670838
- 财政年份:2022
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Family Centered Approaches to Promoting Cascade Screening for Hereditary Cancer Syndromes among African Americans
以家庭为中心的方法促进非裔美国人遗传性癌症综合征的级联筛查
- 批准号:1070888410708884
- 财政年份:2022
- 资助金额:$ 28.2万$ 28.2万
- 项目类别:
Family Centered Approaches to Promoting Cascade Screening for Hereditary Cancer Syndromes among African Americans
以家庭为中心的方法促进非裔美国人遗传性癌症综合征的级联筛查
- 批准号:1052354610523546
- 财政年份:2022
- 资助金额:$ 28.2万$ 28.2万
- 项目类别: